Position in DNA
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$427,259
+$160,506 QoQ
Shares Held
43,114
-0.9% QoQ
Ownership
0.064%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#67
of 183 holders
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DNA Over Time
Shares Held
Position Value (USD)
Derivatives in DNA
reported options exposure · as of Sep 30, 2024CallValue
$448,250
CallShares
55,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026LPL Financial LLC holds $551,304,275 across 203 Biotechnology names. DNA ranks #108 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
289,111 | $143,610,107 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
65,755 | $41,000,872 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
310,761 | $25,330,129 | |
| 4 | ARGX |
Argenx SE
|
19,499 | $18,090,587 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
57,890 | $17,426,626 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
203,557 | $15,932,406 | |
| 7 | RPRX |
Royalty Pharma plc
|
249,117 | $13,967,990 | |
| 8 | INSM |
INSMED Inc
|
128,553 | $13,706,320 |
All Filings in DNA
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $427,259 | 43,114 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $266,753 | 43,516 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $261,989 | 31,527 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $472,581 | 32,413 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $353,947 | 31,462 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $127,469 | 22,363 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $185,882 | 18,929 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $194,923 | 23,917 | Shares | Sole | 2024-11-08 | |
| 2024-09-30 | $448,250 | 55,000 | Call | Sole | 2024-11-08 | |
| 2024-06-30 | $18,370 | 55,000 | Call | Sole | 2024-08-07 | |
| 2024-06-30 | $197,627 | 591,700 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $659,014 | 568,116 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $806,043 | 476,949 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $742,013 | 409,952 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $525,652 | 282,609 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $277,400 | 208,572 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $310,633 | 183,807 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $547,129 | 175,362 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $249,657 | 104,898 | Shares | Sole | 2022-08-12 | |
| 2021-12-31 | $115,999 | 13,959 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $211,517 | 18,250 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||